Growing community of inventors

Groton, CT, United States of America

Vincent Mascitti

Average Co-Inventor Count = 1.73

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 70

Vincent MascittiSpiros Liras (6 patents)Vincent MascittiBenjamin A Thuma (6 patents)Vincent MascittiJennifer A Doudna (1 patent)Vincent MascittiMichael John Munchhof (1 patent)Vincent MascittiKentaro Futatsugi (1 patent)Vincent MascittiMichael P Deninno (1 patent)Vincent MascittiDaniel Wei-Shung Kung (1 patent)Vincent MascittiBenjamin Micah Collman (1 patent)Vincent MascittiRomain Rouet (1 patent)Vincent MascittiRalph Pelton Robinson (1 patent)Vincent MascittiBenjamin M Collman (1 patent)Vincent MascittiBenjamin Thuma (0 patent)Vincent MascittiKim Francis Mcclure (1 patent)Vincent MascittiBenjamin Thuma (1 patent)Vincent MascittiBruce Allen Lefker (1 patent)Vincent MascittiVincent Mascitti (11 patents)Spiros LirasSpiros Liras (18 patents)Benjamin A ThumaBenjamin A Thuma (12 patents)Jennifer A DoudnaJennifer A Doudna (138 patents)Michael John MunchhofMichael John Munchhof (6 patents)Kentaro FutatsugiKentaro Futatsugi (6 patents)Michael P DeninnoMichael P Deninno (1 patent)Daniel Wei-Shung KungDaniel Wei-Shung Kung (7 patents)Benjamin Micah CollmanBenjamin Micah Collman (2 patents)Romain RouetRomain Rouet (1 patent)Ralph Pelton RobinsonRalph Pelton Robinson (1 patent)Benjamin M CollmanBenjamin M Collman (1 patent)Benjamin ThumaBenjamin Thuma (0 patent)Kim Francis McclureKim Francis Mcclure (2 patents)Benjamin ThumaBenjamin Thuma (1 patent)Bruce Allen LefkerBruce Allen Lefker (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Pfizer Corporation (11 from 4,455 patents)

2. University of California (1 from 15,502 patents)


11 patents:

1. 10851367 - Tissue-specific genome engineering using CRISPR-Cas9

2. 10813942 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

3. 10376531 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

4. 10039778 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

5. 9617293 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

6. 9439901 - Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

7. 9439902 - Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

8. 9340553 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

9. 9308204 - Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

10. 8669380 - Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

11. 8080580 - Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/2/2026
Loading…